CN115968924A - Sponge cake with high dietary fiber and low GI and making method thereof - Google Patents
Sponge cake with high dietary fiber and low GI and making method thereof Download PDFInfo
- Publication number
- CN115968924A CN115968924A CN202211677802.7A CN202211677802A CN115968924A CN 115968924 A CN115968924 A CN 115968924A CN 202211677802 A CN202211677802 A CN 202211677802A CN 115968924 A CN115968924 A CN 115968924A
- Authority
- CN
- China
- Prior art keywords
- parts
- dietary fiber
- low
- sponge cake
- sugar substitute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 13
- 239000003765 sweetening agent Substances 0.000 claims abstract description 69
- 235000021092 sugar substitutes Nutrition 0.000 claims abstract description 66
- 150000001875 compounds Chemical class 0.000 claims abstract description 49
- 229930006000 Sucrose Natural products 0.000 claims abstract description 31
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 31
- 229920001202 Inulin Polymers 0.000 claims abstract description 27
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims abstract description 27
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 27
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 27
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 27
- 229940029339 inulin Drugs 0.000 claims abstract description 27
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims abstract description 25
- 229920001353 Dextrin Polymers 0.000 claims abstract description 24
- 239000004375 Dextrin Substances 0.000 claims abstract description 24
- 235000019425 dextrin Nutrition 0.000 claims abstract description 24
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 22
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 22
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 22
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000019202 steviosides Nutrition 0.000 claims abstract description 21
- 239000000811 xylitol Substances 0.000 claims abstract description 21
- 235000010447 xylitol Nutrition 0.000 claims abstract description 21
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 21
- 229960002675 xylitol Drugs 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 12
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 5
- 229940013618 stevioside Drugs 0.000 claims abstract description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000005720 sucrose Substances 0.000 claims description 30
- 229940074410 trehalose Drugs 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000002105 nanoparticle Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- 238000001694 spray drying Methods 0.000 claims description 9
- 239000000428 dust Substances 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 235000020183 skimmed milk Nutrition 0.000 claims description 4
- 238000007908 dry granulation Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 239000008157 edible vegetable oil Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000007493 shaping process Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 238000000527 sonication Methods 0.000 claims 1
- 238000009210 therapy by ultrasound Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 23
- 230000009977 dual effect Effects 0.000 abstract description 3
- 229960004793 sucrose Drugs 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 description 28
- 239000008280 blood Substances 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 24
- 239000004383 Steviol glycoside Substances 0.000 description 16
- 235000019411 steviol glycoside Nutrition 0.000 description 16
- 229930182488 steviol glycoside Natural products 0.000 description 16
- 150000008144 steviol glycosides Chemical class 0.000 description 16
- 239000000543 intermediate Substances 0.000 description 15
- 239000002131 composite material Substances 0.000 description 14
- 239000002245 particle Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 9
- 230000013872 defecation Effects 0.000 description 8
- 230000002641 glycemic effect Effects 0.000 description 8
- 239000008187 granular material Substances 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 235000008429 bread Nutrition 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 241001409321 Siraitia grosvenorii Species 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000008162 cooking oil Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000005176 gastrointestinal motility Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229930189775 mogroside Natural products 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000030595 Glucokinase Human genes 0.000 description 1
- 108010021582 Glucokinase Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 101001062093 Homo sapiens RNA-binding protein 15 Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102100029244 RNA-binding protein 15 Human genes 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 235000021192 high fiber diet Nutrition 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 235000021071 low fiber diet Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及食品制备技术领域,特别是涉及一种高膳食纤维低GI海绵蛋糕及其制作方法。The invention relates to the technical field of food preparation, in particular to a high-dietary-fiber and low-GI sponge cake and a preparation method thereof.
背景技术Background Art
近年来,随着生活水平的不断提高,人们的饮食结构逐渐从过去的低脂肪、低能量密度以及高膳食纤维的饮食结构转变为高脂肪、高能量密度以及低膳食纤维的饮食结构,研究显示,长期的高脂低碳水化合物的摄入可抑制胰岛素分泌,降低胰岛素敏感性,导致糖尿病发生。此外,饮食结构不合理也容易造成胃肠道疾病,比如排便困难等。通过药物治疗糖尿病以及排便困难虽然具有一定的作用,但是长期的药物治疗容易引发多种不良反应,还会造成药物依赖,严重影响了服用者的身体健康和生活质量。In recent years, with the continuous improvement of living standards, people's dietary structure has gradually changed from the past low-fat, low-energy density and high-fiber diet to a high-fat, high-energy density and low-fiber diet. Studies have shown that long-term high-fat and low-carbohydrate intake can inhibit insulin secretion, reduce insulin sensitivity, and lead to diabetes. In addition, an unreasonable dietary structure can easily cause gastrointestinal diseases, such as difficulty in defecation. Although drug treatment for diabetes and difficulty in defecation has a certain effect, long-term drug treatment can easily cause a variety of adverse reactions and cause drug dependence, which seriously affects the health and quality of life of the user.
为了更安全合理地控制血糖和缓解胃肠道问题,人们开始从饮食结构入手。比如,中国专利201010270316.4公开了一种优化的代糖组合物,该组合物包含罗汉果萃取物(罗汉果甙)以及至少一种赤藻糖醇,通过将罗汉果甙V与赤藻糖醇的组成比例控制在50∶50及0.1∶99.9之间,以达成稀释罗汉果萃取物的目的,获得一种低升糖指数(Glycemic index,食物血糖生成指数,简称GI)及低热量的优化代糖组合物。GI是特定食物升高血糖效应与标准食品(如葡萄糖)升高血糖效应之比,是一种衡量碳水化合物如何影响血糖水平的工具,该代糖组合物只是解决了降低GI以及热量的问题,无法解决胃肠道问题。In order to control blood sugar more safely and reasonably and alleviate gastrointestinal problems, people began to start with the dietary structure. For example, Chinese patent 201010270316.4 discloses an optimized sugar substitute composition, which contains monk fruit extract (mogroside) and at least one erythritol. By controlling the composition ratio of mogroside V to erythritol between 50:50 and 0.1:99.9, the purpose of diluting the monk fruit extract is achieved, and a low glycemic index (GI) and low-calorie optimized sugar substitute composition is obtained. GI is the ratio of the blood sugar-raising effect of a specific food to the blood sugar-raising effect of a standard food (such as glucose). It is a tool to measure how carbohydrates affect blood sugar levels. The sugar substitute composition only solves the problem of reducing GI and calories, and cannot solve gastrointestinal problems.
中国专利202010500829.3公开一种润肠通便调节肠道菌群的功能代糖及其制备方法和应用,该功能代糖按重量份数计,包括赤藓糖醇35~75份、菊粉27~55份、甜菊糖0.1~5份、罗汉果糖苷0.1~5份;其提供的功能代糖具有润肠通便和调节肠道菌群失调的功能。但是,该功能代糖没有降低血糖的作用。Chinese patent 202010500829.3 discloses a functional sugar substitute for moistening the intestines, laxative and regulating intestinal flora, and its preparation method and application. The functional sugar substitute includes 35-75 parts of erythritol, 27-55 parts of inulin, 0.1-5 parts of stevioside, and 0.1-5 parts of mogroside by weight; the functional sugar substitute provided by it has the functions of moistening the intestines, laxative and regulating intestinal flora imbalance. However, the functional sugar substitute does not have the effect of lowering blood sugar.
中国专利202110111671.5公开了一种复配功能代糖及其在面包中的应用,提供的一种复配功能代糖,按重量份数计包括菊粉2~5份,麦芽糖醇2~5份,低聚木糖2~5份,海藻糖1~4份,总量为8-12份;通过将复配功能糖代替60%以上的蔗糖,大大减少了面包制作中蔗糖的用量,能够减少由于蔗糖的摄入可能带来的健康问题,同时能改善面包的质构和风味,具有较好的健康意义和实际应用价值。该复配功能代糖只是单纯改善了面包的质构和风味,减少了蔗糖的摄入,无法解决胃肠道问题。Chinese patent 202110111671.5 discloses a compound functional sugar substitute and its application in bread. The compound functional sugar substitute provided includes 2-5 parts of inulin, 2-5 parts of maltitol, 2-5 parts of oligoxylose, and 1-4 parts of trehalose by weight, with a total of 8-12 parts; by replacing more than 60% of sucrose with compound functional sugars, the amount of sucrose used in bread making is greatly reduced, which can reduce the health problems that may be caused by sucrose intake, and at the same time improve the texture and flavor of bread, which has good health significance and practical application value. The compound functional sugar substitute simply improves the texture and flavor of bread, reduces the intake of sucrose, and cannot solve gastrointestinal problems.
发明内容Summary of the invention
本发明的目的是提供一种高膳食纤维低GI海绵蛋糕及其制作方法,以解决上述现有技术存在的问题。The purpose of the present invention is to provide a high-dietary-fiber low-GI sponge cake and a preparation method thereof, so as to solve the problems existing in the above-mentioned prior art.
为实现上述目的,本发明提供了如下方案:To achieve the above object, the present invention provides the following solutions:
一种高膳食纤维低GI海绵蛋糕,在制备过程中加入了复配代糖,所述复配代糖按重量份数计,包括如下原料:抗性糊精3-8份和菊粉4-5份、阿拉伯糖1-2份、阿洛酮糖1-2份、海藻糖1-2份、木糖醇1-2份以及甜菊糖苷0.02-0.04份。A high-dietary-fiber, low-GI sponge cake is prepared by adding a compound sugar substitute, which comprises the following raw materials by weight: 3-8 parts of resistant dextrin, 4-5 parts of inulin, 1-2 parts of arabinose, 1-2 parts of allulose, 1-2 parts of trehalose, 1-2 parts of xylitol and 0.02-0.04 parts of steviol glycoside.
有益效果:阿拉伯糖通过在肠道内对糖类代谢发挥,对蔗糖的代谢转化具有阻断作用,进而起到控制血糖的作用;具体而言,阿拉伯糖能够抑制水解双糖酶,因此抑制因摄入蔗糖而导致的血糖升高;此外,有胃肠道问题的人群在摄入一定量的阿拉伯糖后可以促进其肠道内双歧杆菌的生长,也就是说,阿拉伯糖还具有益生元产品的特征。Beneficial effects: Arabinose has a blocking effect on the metabolic conversion of sucrose by affecting carbohydrate metabolism in the intestine, thereby controlling blood sugar. Specifically, arabinose can inhibit the hydrolysis of disaccharidases, thereby inhibiting the increase in blood sugar caused by the intake of sucrose. In addition, people with gastrointestinal problems can promote the growth of bifidobacteria in their intestines after consuming a certain amount of arabinose. In other words, arabinose also has the characteristics of a prebiotic product.
阿洛酮糖属于己糖与酮糖,具有甜度高、溶解性好和低血糖反应等特点。它能够抑制血浆中的葡萄糖浓度,具体而言,阿洛酮糖可诱导肝葡糖激酶表达,从而提高肝糖原合成,同时,阿洛酮糖还可以减缓β胰岛素细胞的纤维化,其抗糖尿病效果主要是通过维持血糖水平、降低体重增长、控制餐后血糖、减少炎症反应、降低糖化血红蛋白水平实现的。此外,阿洛酮糖还可以与食品蛋白发生美拉德反应,能够改善食品的风味。Allulose belongs to hexose and ketose, and has the characteristics of high sweetness, good solubility and low blood sugar response. It can inhibit the glucose concentration in plasma. Specifically, allulose can induce the expression of liver glucokinase, thereby improving liver glycogen synthesis. At the same time, allulose can also slow down the fibrosis of β-insulin cells. Its anti-diabetic effect is mainly achieved by maintaining blood sugar levels, reducing weight gain, controlling postprandial blood sugar, reducing inflammatory responses, and reducing glycated hemoglobin levels. In addition, allulose can also undergo Maillard reaction with food proteins, which can improve the flavor of food.
木糖醇在体内新陈代谢不需要胰岛素参与,又不使血糖值升高,并可消除糖尿病人三多(多饮、多尿、多食),因此是糖尿病人安全的甜味剂、营养补充剂和辅助治疗。海藻糖具有一定的保湿功能,能够提高制备食品的品质。Xylitol does not require insulin to metabolize in the body, does not increase blood sugar levels, and can eliminate the three polydipsias (polydipsia, polyuria, and polyphagia) of diabetics, so it is a safe sweetener, nutritional supplement, and auxiliary treatment for diabetics. Trehalose has a certain moisturizing function and can improve the quality of prepared food.
抗性糊精可完全溶于冷水,它是以淀粉为原料,通过糊精化过程制备而成,在此过程中淀粉经过一定程度的水解,其后再聚合的过程,形成了不能被消化道内的酶切断因而不可消化的糖苷键,将淀粉转化成纤维,使其具备低GI值,对降低血糖有显著作用,同时还能够促进胃肠道蠕动,解决排便困难的问题。Resistant dextrin is completely soluble in cold water. It is made from starch through a dextrinization process. In this process, the starch undergoes a certain degree of hydrolysis and then polymerizes to form glycosidic bonds that cannot be cut by enzymes in the digestive tract and are therefore indigestible. The starch is converted into fiber, giving it a low GI value, which has a significant effect on lowering blood sugar. It can also promote gastrointestinal motility and solve the problem of difficult defecation.
益生元产品的特征为:有益细菌的增加或有害细菌的减少,肠道pH值的降低以及细菌酶浓度的变化。抗性糊精可通过在结肠发酵,促使消化道内有益菌群增加,降低结肠pH值,并减少潜在治病性菌群。The characteristics of prebiotic products are: increase in beneficial bacteria or decrease in harmful bacteria, decrease in intestinal pH and changes in bacterial enzyme concentration. Resistant dextrin can increase beneficial bacteria in the digestive tract, lower colon pH and reduce potentially pathogenic bacteria through fermentation in the colon.
菊粉是一种天然的水溶性膳食纤维,不能被胃酸水解和消化。被人体摄入后,菊粉可以促进肠胃内益生菌的生长,其具有不被人体吸收而只能被有益菌吸收的特性,使其在具备低GI值不会升高血糖水平的同时,还解决了肠道益生菌过少的问题;此外,菊粉的纤维特性还能增强胃肠道蠕动,提高肠胃功能,能够缓解排便困难等胃肠道疾患。Inulin is a natural water-soluble dietary fiber that cannot be hydrolyzed and digested by gastric acid. After being ingested by the human body, inulin can promote the growth of probiotics in the stomach and intestines. It has the characteristics of not being absorbed by the human body but only by beneficial bacteria, so that it has a low GI value and will not increase blood sugar levels. At the same time, it also solves the problem of too few probiotics in the intestines; in addition, the fiber characteristics of inulin can also enhance gastrointestinal motility, improve gastrointestinal function, and relieve gastrointestinal diseases such as difficulty in defecation.
进一步地,所述复配代糖,按重量份数计,包括如下原料:抗性糊精3份、菊粉5份、阿拉伯糖1份、阿洛酮糖1份、海藻糖1份、木糖醇2份以及甜菊糖苷0.02份。Furthermore, the compound sugar substitute includes the following raw materials in parts by weight: 3 parts of resistant dextrin, 5 parts of inulin, 1 part of arabinose, 1 part of allulose, 1 part of trehalose, 2 parts of xylitol and 0.02 parts of steviol glycoside.
本发明还提供了一种复配代糖的制备方法,包括以下步骤:The present invention also provides a method for preparing a composite sugar substitute, comprising the following steps:
步骤1、分别称取抗性糊精和菊粉,加水溶解后煮沸,冷却,加入乙醇,静置、过滤、烘干、粉碎过筛,得到膳食纤维粉料;Step 1, weighing resistant dextrin and inulin respectively, adding water to dissolve and then boiling, cooling, adding ethanol, standing, filtering, drying, crushing and sieving to obtain dietary fiber powder;
步骤2、分别称取步骤1所述膳食纤维粉料、阿拉伯糖以及阿洛酮糖,溶于水中,混合均匀,超声,喷雾干燥,超微粉碎,得到纳米级颗粒中间体;Step 2, respectively weighing the dietary fiber powder, arabinose and psicose described in step 1, dissolving them in water, mixing them evenly, ultrasonicating, spray drying, and ultrafine grinding to obtain a nano-sized particle intermediate;
步骤3、称取步骤2所述纳米级颗粒中间体,与海藻糖、木糖醇以及甜菊糖苷混合,干法制粒,过筛除尘,得到复配代糖。Step 3: weigh the nano-sized particle intermediate described in step 2, mix it with trehalose, xylitol and steviol glycoside, dry granulate it, sieve it to remove dust, and obtain a compound sugar substitute.
进一步地,步骤1所述抗性糊精和菊粉总质量、水以及乙醇的用量比为(7-13)g∶(2-4)mL∶(1-2)mL;煮沸温度为110-120℃,煮沸时间为20-30min;冷却至75℃以下;静置时间为2-5h;粉碎后过筛100目;步骤2中超声时间为30-60min;步骤3中过筛目数为80目。Furthermore, in step 1, the total mass of the resistant dextrin and inulin, water and ethanol are used in a ratio of (7-13) g: (2-4) mL: (1-2) mL; the boiling temperature is 110-120°C, and the boiling time is 20-30 min; the mixture is cooled to below 75°C; the standing time is 2-5 h; the mixture is sieved through 100 mesh after crushing; the ultrasonic time in step 2 is 30-60 min; and the sieving mesh number in step 3 is 80 mesh.
本发明还提供了一种膳食纤维低GI海绵蛋糕的制作方法,包括以下步骤:将复配代糖和蔗糖混合,加入搅打后的鸡蛋中,搅打后,加入低筋粉、食用油以及脱脂牛奶,搅拌均匀,得到蛋糕液,将蛋糕液定型后烘烤,冷却后包装,即得膳食纤维低GI海绵蛋糕。The present invention also provides a method for making a low-GI sponge cake with dietary fiber, comprising the following steps: mixing a compound sugar substitute and sucrose, adding the mixture to beaten eggs, adding low-gluten flour, edible oil and skimmed milk after beating, stirring evenly to obtain cake liquid, baking the cake liquid after shaping, and packaging the cake liquid after cooling to obtain the low-GI sponge cake with dietary fiber.
进一步地,所述膳食纤维低GI海绵蛋糕的制作方法,其特征在于,所述复配代糖和蔗糖的质量比为1∶2-4∶1。Furthermore, the method for making the dietary fiber low GI sponge cake is characterized in that the mass ratio of the compound sugar substitute to sucrose is 1:2-4:1.
有益效果:海绵蛋糕中蔗糖的含量固定在25%左右,通过控制复合代糖和蔗糖的质量比,加入复配代糖将蔗糖的添加量降低了40%-80%,同时使膳食纤维占总糖的比例高达25-52%,膳食纤维的加入可以抑制血糖升高,具有吸附葡糖糖、油脂的作用,促进排便,改善人体肠道菌群;此外,阿拉伯糖占总糖的比例为4-8%,在该范围内,阿拉伯糖能够对蔗糖的代谢转化具有阻断作用,从而起到了降低血糖的作用。Beneficial effects: The sucrose content in the sponge cake is fixed at about 25%. By controlling the mass ratio of the compound sweetener and sucrose, the addition of the compound sweetener reduces the added amount of sucrose by 40%-80%, and at the same time, the proportion of dietary fiber in the total sugar is as high as 25-52%. The addition of dietary fiber can inhibit the increase of blood sugar, has the function of absorbing glucose and oil, promotes defecation, and improves the intestinal flora of the human body; in addition, the proportion of arabinose in the total sugar is 4-8%. Within this range, arabinose can block the metabolic conversion of sucrose, thereby playing a role in lowering blood sugar.
本发明通过将膳食纤维粉料和阿拉伯糖以及阿洛酮糖合理配伍,通过包埋处理后,将复配代糖中膳食纤维、控糖组分组装为纳米颗粒中间体,保证复配代糖进入消化系统后,膳食纤维以及空糖组分在肠道内均匀释放和高效吸收。The present invention reasonably combines dietary fiber powder with arabinose and allulose, and assembles dietary fiber and sugar-controlling components in the compound sugar substitute into nanoparticle intermediates after an embedding treatment, thereby ensuring that after the compound sugar substitute enters the digestive system, the dietary fiber and the empty sugar components are evenly released and efficiently absorbed in the intestine.
本发明通过将抗性糊精、菊粉、阿拉伯糖、阿洛酮糖、海藻糖、木糖醇以及甜菊糖苷合理复配,得到的复配代糖中不同组分间相互作用,共同达到高膳食纤维,低GI的双重目的。The invention reasonably compounds resistant dextrin, inulin, arabinose, allulose, trehalose, xylitol and steviol glycoside, and different components in the obtained compound sugar substitute interact with each other to achieve the dual purposes of high dietary fiber and low GI.
具体实施方式DETAILED DESCRIPTION
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
为使本发明的上述目的、特征和优点能够更加明显易懂,下面结合具体实施方式对本发明作进一步详细的说明。In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the present invention is further described in detail below in conjunction with specific implementation methods.
本发明实施例中喷雾干燥和干法制粒的过程均为本领域的常规技术手段,且并非本发明重点,在此不做赘述。需要指出的是,干法制粒中所加辅料成分并不会影响海绵蛋糕中膳食纤维含量和GI值。The processes of spray drying and dry granulation in the embodiment of the present invention are conventional technical means in the art and are not the focus of the present invention, and are not described in detail here. It should be pointed out that the auxiliary ingredients added in the dry granulation do not affect the dietary fiber content and GI value in the sponge cake.
实施例1Example 1
复配代糖包括以下重量份数的原料:The compound sugar substitute includes the following raw materials in parts by weight:
抗性糊精3g、菊粉4g、阿拉伯糖1g、阿洛酮糖1g、海藻糖1g、木糖醇1g以及甜菊糖苷0.02g。Resistant dextrin 3g, inulin 4g, arabinose 1g, allulose 1g, trehalose 1g, xylitol 1g and steviol glycoside 0.02g.
复配代糖的制备方法:Preparation method of compound sugar substitute:
1)分别取抗性糊精和菊粉,加2mL水溶解后煮沸至110℃,煮沸时间为25min,冷却至60℃,加入1.5mL乙醇,静置4.5h、过滤、烘干、粉碎后,过100目筛,得到膳食纤维粉料;1) Take resistant dextrin and inulin respectively, add 2 mL of water to dissolve, boil to 110° C. for 25 min, cool to 60° C., add 1.5 mL of ethanol, stand for 4.5 h, filter, dry, grind, and pass through a 100-mesh sieve to obtain dietary fiber powder;
2)将步骤1所述膳食纤维粉料、阿拉伯糖以及阿洛酮糖,溶于水中,混合均匀,超声40min,喷雾干燥,超微粉碎,得到纳米级颗粒中间体;2) dissolving the dietary fiber powder, arabinose and psicose described in step 1 in water, mixing evenly, ultrasonicating for 40 minutes, spray drying, and ultrafine grinding to obtain a nano-sized particle intermediate;
3)称取步骤2所述纳米级颗粒中间体,与海藻糖、木糖醇以及甜菊糖苷混合,干法制粒,过筛80目,除尘,得到复配代糖。3) Weigh the nano-sized particle intermediate described in step 2, mix it with trehalose, xylitol and steviol glycoside, dry granulate it, sieve it through 80 mesh, remove dust, and obtain a composite sugar substitute.
将上述复配代糖与15g蔗糖混合后用于制作海绵蛋糕。The above compound sugar substitute was mixed with 15 g of sucrose and used to prepare sponge cake.
海绵蛋糕的制作方法为:How to make sponge cake:
1)打蛋:将48g鸡蛋液打入搅拌桶内,上搅拌机搅打;1) Beat eggs: put 48g egg liquid into a mixing bucket and beat with a mixer;
2)加糖:添加11g上述复配代糖和15g蔗糖,上搅拌机继续搅打,至泛白并成稠厚乳沫状;2) Adding sugar: Add 11g of the above-mentioned compound sugar substitute and 15g of sucrose, and continue to beat in a blender until it turns white and becomes a thick foam;
3)添加面粉:将20g低筋粉用筛子筛过,分多次倒入搅拌桶中,并加入4g食用油和3g脱脂牛奶,搅和均匀,即得蛋糕液;3) Add flour: sift 20g of low-gluten flour through a sieve, pour it into a mixing bucket in several times, add 4g of cooking oil and 3g of skim milk, stir evenly, and you will get cake liquid;
4)装盘:将预制好的蛋糕液装入烤盘中,定型;4) Plate: Put the prepared cake batter into the baking pan and set it in shape;
5)烘烤:烤箱预热至160℃(或上火160℃、下火160℃),后烘烤40min,待蛋糕完全熟透取出,冷却后包装,即得减糖40%的海绵蛋糕。5) Baking: Preheat the oven to 160°C (or 160°C for upper fire and 160°C for lower fire), bake for 40 minutes, take out the cake when it is fully cooked, cool it down and package it, and you will get a sponge cake with 40% less sugar.
实施例2Example 2
复配代糖包括以下重量份数的原料:The compound sugar substitute includes the following raw materials in parts by weight:
抗性糊精3g、菊粉5g、阿拉伯糖1g、阿洛酮糖1g、海藻糖1g、木糖醇2g以及甜菊糖苷0.02g。Resistant dextrin 3g, inulin 5g, arabinose 1g, allulose 1g, trehalose 1g, xylitol 2g and steviol glycoside 0.02g.
复配代糖的制备方法:Preparation method of compound sugar substitute:
1)分别称取抗性糊精和菊粉,加4mL水溶解后煮沸至120℃,煮沸时间为20min,冷却至60℃,加入2mL乙醇,静置2h、过滤、烘干、粉碎后,过100目筛,得到膳食纤维粉料;1) Weigh resistant dextrin and inulin respectively, add 4 mL of water to dissolve, boil to 120° C. for 20 min, cool to 60° C., add 2 mL of ethanol, let stand for 2 h, filter, dry, grind, and pass through a 100-mesh sieve to obtain dietary fiber powder;
2)将步骤1所述膳食纤维粉料、阿拉伯糖以及阿洛酮糖,溶于水中,混合均匀,超声60min,喷雾干燥,超微粉碎,得到纳米级颗粒中间体;2) dissolving the dietary fiber powder, arabinose and psicose described in step 1 in water, mixing uniformly, ultrasonicating for 60 minutes, spray drying, and ultrafine grinding to obtain a nano-sized particle intermediate;
3)称取步骤2所述纳米级颗粒中间体,与海藻糖、木糖醇以及甜菊糖苷混合,干法制粒,过筛80目,除尘,得到复配代糖。3) Weigh the nano-sized particle intermediate described in step 2, mix it with trehalose, xylitol and steviol glycoside, dry granulate it, sieve it through 80 mesh, remove dust, and obtain a composite sugar substitute.
将上述复配代糖与12.5g蔗糖混合后用于制作海绵蛋糕。The above compound sugar substitute was mixed with 12.5 g of sucrose and used to prepare sponge cake.
海绵蛋糕的制作方法为:How to make sponge cake:
1)打蛋:将48g鸡蛋液打入搅拌桶内,上搅拌机搅打;1) Beat eggs: put 48g egg liquid into a mixing bucket and beat with a mixer;
2)加糖:添加13g上述复配代糖和12.5g蔗糖,上搅拌机继续搅打,至泛白并成稠厚乳沫状;2) Adding sugar: Add 13g of the above-mentioned composite sugar substitute and 12.5g of sucrose, and continue to beat in a blender until it turns white and becomes a thick foam;
3)添加面粉:将20g低筋粉用筛子筛过,分多次倒入搅拌桶中,并加入4g食用油和3g脱脂牛奶,搅和均匀,即得蛋糕液;3) Add flour: sift 20g of low-gluten flour through a sieve, pour it into a mixing bucket in several times, add 4g of cooking oil and 3g of skim milk, stir evenly, and you will get cake liquid;
4)装盘:将预制好的蛋糕液装入烤盘中,定型;4) Plate: Put the prepared cake batter into the baking pan and set it in shape;
5)烘烤:烤箱预热至160℃(或上火160℃、下火160℃),后烘烤40min,待蛋糕完全熟透取出,冷却后包装,即得减糖50%的海绵蛋糕。5) Baking: Preheat the oven to 160°C (or 160°C for upper fire and 160°C for lower fire), bake for 40 minutes, take out the cake when it is fully cooked, cool it down and package it, and you will get a sponge cake with 50% less sugar.
实施例3Example 3
复配代糖包括以下重量份数的原料:The compound sugar substitute includes the following raw materials in parts by weight:
抗性糊精6g、菊粉5g、阿拉伯糖1g、阿洛酮糖1g、海藻糖1g、木糖醇1g以及甜菊糖苷0.03g。Resistant dextrin 6g, inulin 5g, arabinose 1g, allulose 1g, trehalose 1g, xylitol 1g and steviol glycoside 0.03g.
复配代糖的制备方法:Preparation method of compound sugar substitute:
1)分别称取抗性糊精和菊粉,加2mL水溶解后煮沸至115℃,煮沸时间为30min,冷却至60℃,加入1mL乙醇,静置3.5h、过滤、烘干、粉碎后,过100目筛,得到膳食纤维粉料;1) Weigh resistant dextrin and inulin respectively, add 2 mL of water to dissolve, boil to 115° C. for 30 min, cool to 60° C., add 1 mL of ethanol, let stand for 3.5 h, filter, dry, grind, and pass through a 100-mesh sieve to obtain dietary fiber powder;
2)将步骤1所述膳食纤维粉料、阿拉伯糖以及阿洛酮糖,溶于水中,混合均匀,超声30min,喷雾干燥,超微粉碎,得到纳米级颗粒中间体;2) dissolving the dietary fiber powder, arabinose and psicose described in step 1 in water, mixing evenly, ultrasonicating for 30 minutes, spray drying, and ultrafine grinding to obtain a nano-sized particle intermediate;
3)称取步骤2所述纳米级颗粒中间体,与海藻糖、木糖醇以及甜菊糖苷混合,干法制粒,过筛80目,除尘,得到复配代糖。3) Weigh the nano-sized particle intermediate described in step 2, mix it with trehalose, xylitol and steviol glycoside, dry granulate it, sieve it through 80 mesh, remove dust, and obtain a composite sugar substitute.
将上述复配代糖与10g蔗糖混合后用于制作海绵蛋糕。The above compound sugar substitute was mixed with 10 g of sucrose and used to prepare sponge cake.
海绵蛋糕的制作方法通实施例2,不同之处是加入了15g上述复配代糖与10g蔗糖。The method for making the sponge cake is the same as that of Example 2, except that 15 g of the above-mentioned composite sugar substitute and 10 g of sucrose are added.
实施例4Example 4
复配代糖包括以下重量份数的原料:The compound sugar substitute includes the following raw materials in parts by weight:
抗性糊精5g、菊粉5g、阿拉伯糖2g、阿洛酮糖2g、海藻糖2g、木糖醇2g以及甜菊糖苷0.03g。Resistant dextrin 5g, inulin 5g, arabinose 2g, allulose 2g, trehalose 2g, xylitol 2g and steviol glycoside 0.03g.
复配代糖的制备方法:Preparation method of compound sugar substitute:
1)分别称取抗性糊精和菊粉,加4mL水溶解后煮沸至120℃,煮沸时间为20min,冷却至60℃,加入2mL乙醇,静置2h、过滤、烘干、粉碎后,过100目筛,得到膳食纤维粉料;1) Weigh resistant dextrin and inulin respectively, add 4 mL of water to dissolve, boil to 120° C. for 20 min, cool to 60° C., add 2 mL of ethanol, let stand for 2 h, filter, dry, grind, and pass through a 100-mesh sieve to obtain dietary fiber powder;
2)将步骤1所述膳食纤维粉料、阿拉伯糖以及阿洛酮糖,溶于水中,混合均匀,超声60min,喷雾干燥,超微粉碎,得到纳米级颗粒中间体;2) dissolving the dietary fiber powder, arabinose and psicose described in step 1 in water, mixing uniformly, ultrasonicating for 60 minutes, spray drying, and ultrafine grinding to obtain a nano-sized particle intermediate;
3)称取步骤2所述纳米级颗粒中间体,与海藻糖、木糖醇以及甜菊糖苷混合,干法制粒,过筛80目,除尘,得到复配代糖。3) Weigh the nano-sized particle intermediate described in step 2, mix it with trehalose, xylitol and steviol glycoside, dry granulate it, sieve it through 80 mesh, remove dust, and obtain a composite sugar substitute.
将上述复配代糖与7.5g蔗糖混合后用于制作海绵蛋糕。The above compound sugar substitute was mixed with 7.5 g of sucrose and used to prepare sponge cake.
海绵蛋糕的制作方法同实施例2,不同之处在于加入了18g上述复配代糖与7.5g蔗糖。The preparation method of the sponge cake is the same as that of Example 2, except that 18 g of the above-mentioned composite sugar substitute and 7.5 g of sucrose are added.
实施例5Example 5
复配代糖包括以下重量份数的原料:The compound sugar substitute includes the following raw materials in parts by weight:
抗性糊精8g、菊粉5g、阿拉伯糖2g、阿洛酮糖1g、海藻糖2g、木糖醇2g以及甜菊糖苷0.04g。Resistant dextrin 8g, inulin 5g, arabinose 2g, allulose 1g, trehalose 2g, xylitol 2g and steviol glycoside 0.04g.
复配代糖的制备方法:Preparation method of compound sugar substitute:
1)分别称取抗性糊精和菊粉,加4mL水溶解后煮沸至120℃,煮沸时间为20min,冷却至60℃,加入2mL乙醇,静置2h、过滤、烘干、粉碎后,过100目筛,得到膳食纤维粉料;1) Weigh resistant dextrin and inulin respectively, add 4 mL of water to dissolve, boil to 120° C. for 20 min, cool to 60° C., add 2 mL of ethanol, let stand for 2 h, filter, dry, grind, and pass through a 100-mesh sieve to obtain dietary fiber powder;
2)将步骤1所述膳食纤维粉料、阿拉伯糖以及阿洛酮糖,溶于水中,混合均匀,超声60min,喷雾干燥,超微粉碎,得到纳米级颗粒中间体;2) dissolving the dietary fiber powder, arabinose and psicose described in step 1 in water, mixing uniformly, ultrasonicating for 60 minutes, spray drying, and ultrafine grinding to obtain a nano-sized particle intermediate;
3)称取步骤2所述纳米级颗粒中间体,与海藻糖、木糖醇以及甜菊糖苷混合,干法制粒,过筛80目,除尘,得到复配代糖。3) Weigh the nano-sized particle intermediate described in step 2, mix it with trehalose, xylitol and steviol glycoside, dry granulate it, sieve it through 80 mesh, remove dust, and obtain a composite sugar substitute.
将上述复配代糖与5g蔗糖混合后用于制作海绵蛋糕。The above compound sugar substitute was mixed with 5 g of sucrose and used to prepare sponge cake.
海绵蛋糕的制作方法同实施例2,不同之处在于加入了20g上述复配代糖以及5g蔗糖。The preparation method of the sponge cake is the same as that of Example 2, except that 20 g of the above-mentioned composite sugar substitute and 5 g of sucrose are added.
实施例6Example 6
复配代糖包括以下重量份数的原料:The compound sugar substitute includes the following raw materials in parts by weight:
抗性糊精8g、菊粉5g、阿拉伯糖2g、阿洛酮糖1g、海藻糖2g、木糖醇2g以及甜菊糖苷0.04g。Resistant dextrin 8g, inulin 5g, arabinose 2g, allulose 1g, trehalose 2g, xylitol 2g and steviol glycoside 0.04g.
复配代糖的制备方法:Preparation method of compound sugar substitute:
1)分别称取抗性糊精和菊粉,加4mL水溶解后煮沸至120℃,煮沸时间为20min,冷却至60℃,加入2mL乙醇,静置2h、过滤、烘干、粉碎后,过100目筛,得到膳食纤维粉料;1) Weigh resistant dextrin and inulin respectively, add 4 mL of water to dissolve, boil to 120° C. for 20 min, cool to 60° C., add 2 mL of ethanol, let stand for 2 h, filter, dry, grind, and pass through a 100-mesh sieve to obtain dietary fiber powder;
2)将步骤1所述膳食纤维粉料、阿拉伯糖以及阿洛酮糖,溶于水中,混合均匀,超声60min,喷雾干燥,超微粉碎,得到纳米级颗粒中间体;2) dissolving the dietary fiber powder, arabinose and psicose described in step 1 in water, mixing uniformly, ultrasonicating for 60 minutes, spray drying, and ultrafine grinding to obtain a nano-sized particle intermediate;
3)称取步骤2所述纳米级颗粒中间体,与海藻糖、木糖醇以及甜菊糖苷混合,干法制粒,过筛80目,除尘,得到复配代糖。3) Weigh the nano-sized particle intermediate described in step 2, mix it with trehalose, xylitol and steviol glycoside, dry granulate it, sieve it through 80 mesh, remove dust, and obtain a composite sugar substitute.
将上述复配代糖与5g蔗糖混合后用于制作海绵蛋糕。The above compound sugar substitute was mixed with 5 g of sucrose and used to prepare sponge cake.
海绵蛋糕的制作方法同实施例2,不同之处在于加入了8.5g上述复配代糖以及16.5g蔗糖。The preparation method of the sponge cake is the same as that of Example 2, except that 8.5 g of the above-mentioned composite sugar substitute and 16.5 g of sucrose are added.
对比例1Comparative Example 1
同实施例2,不同之处为制备海绵蛋糕时,只加入25g蔗糖,不加入复配代糖。The same as Example 2, except that when preparing the sponge cake, only 25 g of sucrose was added, and no composite sugar substitute was added.
对比例2-3Comparative Examples 2-3
同实施例2,不同之处在于,复配代糖与蔗糖的质量比不同,详见表1。Same as Example 2, except that the mass ratio of the compound sugar substitute to sucrose is different, see Table 1 for details.
表1Table 1
对比例4-7Comparative Examples 4-7
一种复配代糖,按照重量份计,包括以下原料,详见表2。A compound sugar substitute comprises the following raw materials in parts by weight, as shown in Table 2.
表2Table 2
分别采用对比例4-7中的复配代糖,通过实施例2中海绵蛋糕的制作方法得到海绵蛋糕。The composite sugar substitutes in Comparative Examples 4-7 were respectively used to obtain sponge cakes using the sponge cake making method in Example 2.
技术效果Technical Effects
1、感官评价1. Sensory evaluation
重复实施2以及对比例1-7,得到足够多的蛋糕,调研100人,其中20-30岁年龄段占25%、31-40岁年龄段占25%、41-50岁年龄段占25%、51-60岁年龄段占25%,感官评价标准见表3,感官评价结果见表4。Repeat implementation 2 and comparative examples 1-7 to obtain enough cakes and survey 100 people, of which 25% are in the 20-30 age group, 25% are in the 31-40 age group, 25% are in the 41-50 age group, and 25% are in the 51-60 age group. The sensory evaluation standards are shown in Table 3, and the sensory evaluation results are shown in Table 4.
表3感官评价标准Table 3 Sensory evaluation standards
表4感官评价结果Table 4 Sensory evaluation results
2、GI(食物血糖生成指数)测定2. GI (food glycemic index) determination
GI(食物血糖生成指数)是指某种食物升高血糖效应与标准食品(通常为葡萄糖)升高血糖效应的比值,代表的是人体食用一定量的某种食物后会引起多大的血糖反应。它通常反映了一个食物能够引起人体血糖升高多少的能力,当GI在55以下时,可认为该食物为低GI食物;当GI在55~70之间时,该食物为中等GI食物;当GI在70以上时,该食物为高GI食物。GI (food glycemic index) refers to the ratio of the blood sugar-raising effect of a certain food to the blood sugar-raising effect of a standard food (usually glucose), which represents how much blood sugar response a certain amount of food will cause in the human body. It usually reflects how much a food can cause the human body's blood sugar to rise. When the GI is below 55, the food can be considered a low GI food; when the GI is between 55 and 70, the food is a medium GI food; when the GI is above 70, the food is a high GI food.
对实施例2以及对比例1-7所得海绵蛋糕进行GI(食物血糖生成指数)指标检测。The sponge cakes obtained in Example 2 and Comparative Examples 1-7 were tested for GI (food glycemic index).
表5Table 5
3、GL(食物血糖负荷)指标测定3. GL (food glycemic load) index determination
GL(食物血糖负荷)代表的是实际摄入碳水的量对血糖的影响,当GL≥20时,为高负荷饮食,表示对血糖影响较大;当GL在11-19之间,为中负荷饮食,表示对血糖影响中等;当GL≤10时,为低负荷饮食,表示对血糖影响较小。GL (food glycemic load) represents the impact of the actual amount of carbohydrate intake on blood sugar. When GL≥20, it is a high-load diet, indicating a greater impact on blood sugar; when GL is between 11-19, it is a medium-load diet, indicating a moderate impact on blood sugar; when GL≤10, it is a low-load diet, indicating a smaller impact on blood sugar.
对实施例2以及对比例1-7所得海绵蛋糕进行GL(食物血糖负荷)指标检测,结果见表6。The sponge cakes obtained in Example 2 and Comparative Examples 1-7 were tested for GL (food glycemic load) index, and the results are shown in Table 6.
表6Table 6
4、对胃肠道问题的缓解测试4. Test for relief of gastrointestinal problems
对80个存在排便困难的老年人(60-75岁之间)进行测试,平均分为8组,每组10个人,各自连续3天食用实施例2以及对比例1-7制作的海绵蛋糕,统计缓解排便困难有效率,结果见表7。80 elderly people (60-75 years old) with defecation difficulties were tested and divided into 8 groups, each with 10 people. Each of them ate the sponge cakes prepared in Example 2 and Comparative Examples 1-7 for 3 consecutive days. The effective rate of relieving defecation difficulties was statistically analyzed. The results are shown in Table 7.
表7Table 7
通过上述技术效果可知∶将蔗糖与本发明提供的复配代糖按照合适比例混合后,用于制作海绵蛋糕,所得蛋糕不仅口感良好,还可以达到高膳食纤维和低GI和低GL的双重目的,既可以缓解排便困难的问题,还可以有效控制血糖。It can be seen from the above technical effects that after sucrose and the compound sugar substitute provided by the present invention are mixed in a suitable proportion and used to make sponge cake, the obtained cake not only has a good taste, but also can achieve the dual purposes of high dietary fiber and low GI and low GL, which can not only alleviate the problem of difficult defecation, but also effectively control blood sugar.
以上所述的实施例仅是对本发明的优选方式进行描述,并非对本发明的范围进行限定,在不脱离本发明设计精神的前提下,本领域普通技术人员对本发明的技术方案做出的各种变形和改进,均应落入本发明权利要求书确定的保护范围内。The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211677802.7A CN115968924A (en) | 2022-12-26 | 2022-12-26 | Sponge cake with high dietary fiber and low GI and making method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211677802.7A CN115968924A (en) | 2022-12-26 | 2022-12-26 | Sponge cake with high dietary fiber and low GI and making method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115968924A true CN115968924A (en) | 2023-04-18 |
Family
ID=85959222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211677802.7A Pending CN115968924A (en) | 2022-12-26 | 2022-12-26 | Sponge cake with high dietary fiber and low GI and making method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115968924A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12264176B2 (en) | 2016-10-28 | 2025-04-01 | Tate & Lyle Solutions Usa Llc | Method for producing allulose crystals |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103053903A (en) * | 2012-12-29 | 2013-04-24 | 北京中科邦尼国际科技有限责任公司 | Compound functional sugar with function of reducing food glycemic indexes |
CN107736556A (en) * | 2017-10-17 | 2018-02-27 | 徐州工程学院 | Low sugar content and high fiber content health cake steaming and its production method |
CN111011730A (en) * | 2019-12-24 | 2020-04-17 | 玛士撒拉(上海)医疗科技有限公司 | Low-GI steamed cake rich in dietary fiber and preparation method thereof |
CN111557405A (en) * | 2020-06-01 | 2020-08-21 | 潍坊易北特健康食品有限公司 | Solid beverage rich in dietary fiber and plant-based sugar substitutes and preparation method thereof |
CN114258929A (en) * | 2021-12-30 | 2022-04-01 | 浙江华康药业股份有限公司 | Baked bread and preparation method thereof |
CN114651982A (en) * | 2022-03-22 | 2022-06-24 | 北大荒完达山乳业股份有限公司 | Composition capable of delaying postprandial blood sugar, preparation method and application thereof |
WO2024113342A1 (en) * | 2022-12-02 | 2024-06-06 | 黑龙江八一农垦大学 | Preparation method for low-auxiliary-material bread |
-
2022
- 2022-12-26 CN CN202211677802.7A patent/CN115968924A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103053903A (en) * | 2012-12-29 | 2013-04-24 | 北京中科邦尼国际科技有限责任公司 | Compound functional sugar with function of reducing food glycemic indexes |
CN107736556A (en) * | 2017-10-17 | 2018-02-27 | 徐州工程学院 | Low sugar content and high fiber content health cake steaming and its production method |
CN111011730A (en) * | 2019-12-24 | 2020-04-17 | 玛士撒拉(上海)医疗科技有限公司 | Low-GI steamed cake rich in dietary fiber and preparation method thereof |
CN111557405A (en) * | 2020-06-01 | 2020-08-21 | 潍坊易北特健康食品有限公司 | Solid beverage rich in dietary fiber and plant-based sugar substitutes and preparation method thereof |
CN114258929A (en) * | 2021-12-30 | 2022-04-01 | 浙江华康药业股份有限公司 | Baked bread and preparation method thereof |
CN114651982A (en) * | 2022-03-22 | 2022-06-24 | 北大荒完达山乳业股份有限公司 | Composition capable of delaying postprandial blood sugar, preparation method and application thereof |
WO2024113342A1 (en) * | 2022-12-02 | 2024-06-06 | 黑龙江八一农垦大学 | Preparation method for low-auxiliary-material bread |
Non-Patent Citations (4)
Title |
---|
晏日安,林楠,逯与运,等: "纽甜在蛋糕中应用的研究", 《食品研究与开发》, vol. 34, no. 15, 10 August 2013 (2013-08-10), pages 134 - 136 * |
王建彬,李俊霖,郭传庄,等: "几种重要稀有糖的特性及研究进展", 《食品工业》, vol. 42, no. 8, 20 August 2021 (2021-08-20), pages 200 - 204 * |
王振丽,徐明磊: "无糖低GI海绵蛋糕的研制", 《食品工业》, vol. 43, no. 2, 20 February 2022 (2022-02-20), pages 62 - 66 * |
郝月慧,汤晓娟,黄卫宁,等: "糖醇对鸡蛋液功能特性及无糖海绵蛋糕烘焙品质的影响", 《食品工业科技》, vol. 36, no. 3, 1 February 2015 (2015-02-01), pages 49 - 53 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12264176B2 (en) | 2016-10-28 | 2025-04-01 | Tate & Lyle Solutions Usa Llc | Method for producing allulose crystals |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105166759B (en) | A kind of high dietary-fiber coconut powder and application thereof | |
CN111011862B (en) | Edible composition, low glycemic index nutrition powder and preparation method thereof | |
CN105212228A (en) | A kind of nutritious powder for hypoglycemia patient | |
CN105995993A (en) | Food composition applicable to diabetic and preparation method thereof | |
CN108174900A (en) | The hypoglycemia generation value that a kind of suitable diabetic population is eaten(GI)Biscuit | |
CN106820069A (en) | A kind of natural built-up sweetener with regulating intestinal canal function and preparation method thereof | |
CN105145843A (en) | High-fiber oat and milk beverage and production method thereof | |
CN101999597A (en) | Instant barley highland cereal for reducing cholesterol and preparation method thereof | |
JP3541200B2 (en) | Method for imparting an effect of preventing obesity and glucose intolerance to food, food and sugar preparation having the same effect | |
CN114223690A (en) | Method for preparing low-GI bread by fermenting grains with probiotics | |
CN115968924A (en) | Sponge cake with high dietary fiber and low GI and making method thereof | |
CN105146316B (en) | A kind of steamed bun and its production method containing soyabean oligosaccharides | |
CN110089540A (en) | A kind of bread and preparation method thereof containing high-resistance starch and rhizoma polygonati | |
CN112617212A (en) | Blood sugar reducing meal replacement powder and preparation method thereof | |
CN111990630A (en) | A kind of low sugar syrup and preparation method thereof | |
CN107373319A (en) | One kind controls sugared cereal and reconstitutes instant product | |
CN108477262B (en) | Premixed flour and preparation method thereof | |
CN106942587A (en) | A kind of production method of coarse grain steamed bread | |
CN111202107A (en) | Purple sweet potato rock tea biscuits with low GI value and preparation method thereof | |
CN111165534B (en) | Slow-digestion type whole grain energy bar and preparation method thereof | |
CN119302399B (en) | A tartary buckwheat complex with auxiliary blood sugar lowering effect and its preparation method and application | |
CN108125220A (en) | The pueraria lobata of internal blood sugar concentration and starch absorption be can inhibit for food product and preparation method thereof | |
CN107467492A (en) | A kind of saccharide-controlled wheat flour | |
CN115380933A (en) | Zero-sugar low-calorie sponge cake and preparation method thereof | |
CN106165718A (en) | A kind of control sugar short crust pastry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |